Metropolitan Life Insurance CO Madrigal Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$171.37 - $283.23 $10,796 - $17,843	-63 Reduced 7.49%	778 $207,000
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $6,742 - $13,279	56 Added 7.13%	841 $194,000
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $5,987 - $9,256	41 Added 5.51%	785 $114,000
Q2 2023 Aug 10, 2023	BUY	$203.88 - $312.0 $12,844 - $19,656	63 Added 9.25%	744 $171,000
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $18,715 - $24,873	-81 Reduced 10.63%	681 $164,000
Q4 2022 Jun 14, 2023	BUY	$58.39 - $296.54 $4,729 - $24,019	81 Added 11.89%	762 $221 Million
Q3 2022 Jun 14, 2023	BUY	$60.57 - $79.51 $4,906 - $6,440	81 Added 11.89%	762 $49.5 Million
Q2 2022 Jun 20, 2023	BUY	$58.04 - $100.2 $4,701 - $8,116	81 Added 11.89%	762 $54,000
Q1 2022 Jun 20, 2023	BUY	$55.89 - $101.89 $4,527 - $8,253	81 Added 11.89%	762 $74,000
Q1 2022 Mar 30, 2023	SELL	$55.89 - $101.89 $137,936 - $251,464	-2,468 Reduced 76.41%	762 $74,000
Q1 2022 May 12, 2022	SELL	$55.89 - $101.89 $137,936 - $251,464	-2,468 Reduced 76.41%	762 $75,000
Q4 2021 Jun 21, 2023	BUY	$72.34 - $95.09 $184,394 - $242,384	2,549 Added 374.3%	3,230 $273,000
Q3 2021 Jun 21, 2023	BUY	$78.35 - $105.02 $199,714 - $267,695	2,549 Added 374.3%	3,230 $257,000
Q2 2021 Jun 21, 2023	BUY	$97.2 - $137.59 $247,762 - $350,716	2,549 Added 374.3%	3,230 $314,000
Q2 2021 Mar 30, 2023	BUY	$97.2 - $137.59 $67,068 - $94,937	690 Added 27.17%	3,230 $314,000
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $313,664 - $444,002	3,227 Added 107566.67%	3,230 $315,000
Q1 2021 Jun 26, 2023	BUY	$108.54 - $125.2 $201,775 - $232,746	1,859 Added 272.98%	2,540 $297 Million
Q1 2021 Mar 30, 2023	SELL	$108.54 - $125.2 $13,893 - $16,025	-128 Reduced 4.8%	2,540 $297,000
Q1 2021 May 14, 2021	SELL	$108.54 - $125.2 $289,259 - $333,658	-2,665 Reduced 99.89%	3 $297,000
Q4 2020 Jun 22, 2023	BUY	$110.06 - $133.7 $218,689 - $265,661	1,987 Added 291.78%	2,668 $296,000
Q3 2020 Jun 26, 2023	BUY	$99.78 - $124.21 $198,262 - $246,805	1,987 Added 291.78%	2,668 $316,000
Q2 2020 Jun 26, 2023	BUY	$60.13 - $125.71 $119,478 - $249,785	1,987 Added 291.78%	2,668 $302,000
Q1 2020 Jul 12, 2023	BUY	$66.76 - $93.49 $132,652 - $185,764	1,987 Added 291.78%	2,668 $178,000
Q4 2019 Jul 12, 2023	BUY	$84.28 - $118.5 $167,464 - $235,459	1,987 Added 291.78%	2,668 $243,000
Q3 2019 Jul 12, 2023	BUY	$84.4 - $106.53 $167,702 - $211,675	1,987 Added 291.78%	2,668 $230,000
Q3 2019 Mar 30, 2023	BUY	$84.4 - $106.53 $34,266 - $43,251	406 Added 17.95%	2,668 $230,000
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $34,266 - $43,251	406 Added 17.95%	2,668 $230,000
Q2 2019 Jul 12, 2023	BUY	$91.13 - $142.5 $152,004 - $237,690	1,668 Added 244.93%	2,349 $246,000
Q1 2019 Jul 13, 2023	BUY	$103.48 - $143.84 $163,601 - $227,411	1,581 Added 232.16%	2,262 $283,000
Q1 2019 Mar 30, 2023	BUY	$103.48 - $143.84 $155,220 - $215,760	1,500 Added 196.85%	2,262 $283,000
Q1 2019 May 16, 2019	SELL	$103.48 - $143.84 $5.18 Million - $7.2 Million	-50,045 Reduced 95.68%	2,262 $283,000
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $5.18 Million - $7.2 Million	50,045 Added 2212.42%	52,307 $2.59 Million
Q4 2018 Jul 13, 2023	BUY	$94.77 - $215.54 $149,831 - $340,768	1,581 Added 232.16%	2,262 $254,000
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $167,458 - $380,859	1,767 Added 356.97%	2,262 $255,000
Q3 2018 Jul 13, 2023	BUY	$207.3 - $300.31 $327,741 - $474,790	1,581 Added 232.16%	2,262 $484 Million
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $297,268 - $430,644	-1,434 Reduced 74.34%	495 $106,000
Q2 2018 Aug 15, 2018	BUY	$101.55 - $313.9 $48,744 - $150,672	480 Added 33.13%	1,929 $0
Q4 2017 Feb 15, 2018	BUY	$39.35 - $97.37 $57,018 - $141,089	1,449	1,449 $133,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

21.9M

Call Options Held

757K

Put Options Held

370K

Janus Henderson Group PLC London, X0

2.49M
Shares

$539 Million
0.38% of portfolio
Avoro Capital Advisors LLC New York, NY

2.06M
Shares

$446 Million
7.86% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$428 Million
7.35% of portfolio
Rtw Investments, LP New York, NY

1.92M
Shares

$416 Million
8.96% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

1.85M
Shares

$401 Million
39.74% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.71B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account